Abstract: Disclosed are novel compounds of Chemical Formula 1, optical isomers of the compounds, and pharmaceutically acceptable salts of the compounds or the optical isomers. The compounds, isomers, and salts exhibit excellent activity as GLP-1 receptor agonists. In particular, they, as GLP-1 receptor agonists, exhibit excellent glucose tolerance, thus having a great potential to be used as therapeutic agents for metabolic diseases. Moreover, they exhibit excellent pharmacological safety for cardiovascular systems.

Abstract: A current sensing circuit includes a power transistor, a sensing transistor configured to copy a current flowing through the power transistor at a predetermined ratio, a current sensing resistor configured to detect a voltage from the current copied by the sensing transistor, an input resistor configured to convert an input voltage to a current, a cross self-biasing cascade block configured to adjust currents at both ends of the input resistor, and a common gate transistor and a reference resistor configured to convert a current output of the input resistor to a final sense voltage.

Abstract: A current sensing circuit includes a power transistor, a sensing transistor configured to copy a current flowing through the power transistor at a predetermined ratio, a current sensing resistor configured to detect a voltage from the current copied by the sensing transistor, an input resistor configured to convert an input voltage to a current, a cross self-biasing cascade block configured to adjust currents at both ends of the input resistor, and a common gate transistor and a reference resistor configured to convert a current output of the input resistor to a final sense voltage.